Suwon, South Korea

Eun Chan Park

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Amkor Pharma, Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eun Chan Park. Retrieved from https://idiyas.com/inventor/eun-chan-park-vxzjhmzz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eun Chan Park - Innovator in Neurodegenerative Disease Treatment

Introduction

Eun Chan Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. His innovative work focuses on developing effective solutions for conditions that affect the central nervous system.

Latest Patents

Eun Chan Park holds a patent for "Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same." This invention relates to a tetrafluorobenzyl derivative and a pharmaceutical composition aimed at preventing and treating both acute and chronic neurodegenerative diseases, as well as ophthalmic diseases. The derivative has shown potential in effectively addressing chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, along with degenerative brain diseases like epilepsy and ischemic brain conditions such as stroke.

Career Highlights

Eun Chan Park is currently associated with Amkor Pharma, Inc., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in creating innovative treatments that can improve the quality of life for patients suffering from debilitating neurological conditions.

Collaborations

Eun Chan Park collaborates with esteemed colleagues, including Byoung Joo Gwag and Sung Hwa Yoon. Their combined expertise enhances the research and development process, leading to groundbreaking advancements in the field.

Conclusion

Eun Chan Park's contributions to the treatment of neurodegenerative diseases through his innovative patent highlight his role as a significant inventor in the pharmaceutical industry. His work not only showcases his dedication to improving healthcare but also emphasizes the importance of collaboration in achieving scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…